Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics save search
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Published: 2024-04-12 (Crawled : 20:00) - globenewswire.com
AQST | $4.11 -8.67% -9.49% 2.3M
|
Health Technology
| Email alert
Add to watchlist
neurology for meeting therapeutics study
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.17%
H: 0.17%
C: -1.9%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: -2.01%
H: 1.37%
C: -5.92%
daxxify neurology meeting
NeuroSense to Present PARADIGM Data at the American Academy of Neurology Annual Meeting April 16, 2024
Published: 2024-04-12 (Crawled : 12:30) - prnewswire.com
NRSN | $1.435 -5.59% -5.92% 120K
|
|
| O: 16.03%
H: 0.0%
C: -11.6%
neurology meeting
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
Published: 2024-04-12 (Crawled : 12:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K
|
Professional, Scientific, and T...
|
| O: -4.19%
H: 9.38%
C: 1.25%
conference therapeutics foundation
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
Published: 2024-04-12 (Crawled : 04:00) - globenewswire.com
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.32%
H: 2.19%
C: 1.76%
million offering therapeutics
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen
Published: 2024-04-12 (Crawled : 02:00) - prnewswire.com
AMPL | $9.48 0.21% 0.21% 300K
|
|
| O: -0.44%
H: 0.0%
C: 0.0%
OCGN | News A | $1.315 -0.38% -0.38% 6.5M
|
Health Technology
|
| O: -8.65%
H: 4.14%
C: 1.18%
CKPT | $1.47 -8.13% -8.84% 760K
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
deadline
Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024
Published: 2024-04-11 (Crawled : 21:00) - prnewswire.com
CVKD | $0.401 -6.7% -7.18% 67K
|
|
| O: -5.3%
H: 8.26%
C: -0.05%
conference therapeutics growth
Relay Therapeutics to Participate in Upcoming Investor Conferences
Published: 2024-04-11 (Crawled : 20:00) - globenewswire.com
RLAY | $5.96 -2.46% -2.52% 2.4M
|
Health Technology
|
| O: 0.56%
H: 0.14%
C: -1.95%
relay therapeutics
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
PTCT | News S | $25.32 2.55% 2.49% 3.9M
|
Health Technology
|
| O: 2.01%
H: 1.35%
C: -0.18%
first conference therapeutics financial results
Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: 1.08%
H: 1.19%
C: 0.85%
conference for therapeutics
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
VSTM | $9.86 -3.62% -3.75% 150K
|
Health Technology
|
| O: -0.4%
H: 4.84%
C: 4.79%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
medical therapeutics
Black Diamond Therapeutics Announces Changes to Board of Directors - April 11, 2024
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BDTX | $5.26 -0.76% -0.76% 390K
|
Health Technology
|
| O: -3.01%
H: 11.9%
C: 11.4%
therapeutics
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
Published: 2024-04-11 (Crawled : 20:00) - prnewswire.com
HRTX M | $2.63 -2.95% -3.04% 2.3M
|
Health Technology
|
| O: -0.34%
H: 4.78%
C: -0.68%
day city therapeutics
Nurix Therapeutics Announces Proposed Public Offering
Published: 2024-04-11 (Crawled : 20:00) - globenewswire.com
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.32%
H: 2.19%
C: 1.76%
offering therapeutics
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: -59.52%
H: 0.0%
C: 0.0%
million offering therapeutics
Leap Therapeutics Announces $40 Million Private Placement
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LPTX | $2.81 -5.07% -5.34% 200K
|
Health Technology
|
| O: 15.13%
H: 25.43%
C: -11.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
million leap therapeutics
Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis
Published: 2024-04-11 (Crawled : 19:00) - globenewswire.com
ENLV | $1.4 -4.23% 110K
|
Health Technology
|
| O: 3.28%
H: 2.12%
C: -16.4%
topline trial results
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
Published: 2024-04-11 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
RLYB | News | $1.75 4.79% 4.57% 310K
|
|
| O: 104.91%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
VXRT | News | $0.7652 -9.15% -10.08% 1.9M
|
Health Technology
|
| O: 0.0%
H: 2.97%
C: 2.97%
TXMD | News | $1.86 -1.59% -1.61% 10K
|
Health Technology
|
| O: -0.47%
H: 0.48%
C: -0.95%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
PTCT | News S | $25.32 2.55% 2.49% 3.9M
|
Health Technology
|
| O: 2.01%
H: 1.35%
C: -0.18%
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 8.53%
H: 25.0%
C: 12.86%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.39%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: 0.55%
H: 0.29%
C: -1.41%
AMRN | News | $0.88 0.94% 0.93% 1M
|
Health Technology
|
| O: 0.0%
H: 0.96%
C: -1.92%
GOOGL | News S | $154.08 -1.24% -1.25% 32M
|
Technology Services
|
| O: 0.49%
H: 1.77%
C: 1.59%
GOOG | News S | $155.7 -1.12% -1.13% 20M
|
Technology Services
|
| O: 0.43%
H: 1.76%
C: 1.55%
OCX | News J | $2.495 -2.54% -2.61% 50K
|
Health Technology
|
| O: -1.62%
H: 4.43%
C: 3.67%
biopharma novartis
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Published: 2024-04-11 (Crawled : 13:00) - globenewswire.com
CADL | $5.17 -5.31% -5.61% 520K
|
|
| O: 25.49%
H: 23.75%
C: 13.75%
can-2409 fda drug cancer pancreatic treatment designation for therapeutics
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
ENLV | $1.4 -4.23% 110K
|
Health Technology
|
| O: -44.19%
H: 1.36%
C: -17.19%
topline trial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.